THIS CONTENT IS INTENDED FOR HEALTHCARE PROFESSIONALS
Pfizer is committed to changing the conversation in advanced prostate cancer (aPC) by shining a light on inequities in care and exploring the causes behind them.
With a long-standing dedication to research and treatment, we are creating partnerships to promote equitable care for everyone with advanced prostate cancer, no matter who they are or where they live. In collaboration with the American Cancer Society, we’ve awarded six grants for local health system quality improvement projects aimed at reducing disparities among Black men in prostate cancer care.
The Pfizer Multicultural Health Equity Collective engages over 40 organizations to improve health equity across ethnic groups and other underrepresented communities facing significant health disparities.
Pfizer’s Diversity in Clinical Trials Center of Excellence supports clinical trial teams in meeting diversity goals by:
Educating communities about a variety of disease states, including oncology.